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Protocol
========

1. Preparing Reagents
---------------------

1.  For sterile vaginal lavage, autoclave double distilled water (ddH~2~O) and store in a tightly sealed container at room temperature until needed.

2.  For cytological assessment, add 0.1 g of crystal violet powder to 100 ml of ddH~2~O. Mix well. Crystal violet stain (0.1%) can be stored in a tightly sealed container at room temperature until needed.

2. Collecting Vaginal Cells (Vaginal Lavage)
--------------------------------------------

1.  Place a latex bulb on the end of a sterile 200 μl tip and draw up approximately 100 μl of sterile ddH~2~O using the gradations on the tip as a volume guideline.

2.  Lift the mouse out of her cage and place her on the cage hopper (lid) with her hind/rear end towards you.

3.  Firmly grasp the tail and elevate the rear end. The mouse will now have only her front paws grasping the hopper. At this point the mouse may urinate. If so, wait until urination stops. Should there be urine left at the entrance to the vaginal canal, you may want to rinse the opening with excess ddH~2~O using a separate tip (*i.e.*, not your sample collection tip).

4.  Place the end of the ddH~2~O-filled tip at the opening of the vaginal canal taking care to not penetrate the orifice as vaginal (and cervical) stimulation can induce pseudopregnancy in rats^1,2^. Recent reports suggest mice are less susceptible to this effect nonetheless care should be taken to minimize the degree of invasiveness in repeated analyses^3^.

5.  Gently depress the bulb to expel a quarter to half of the volume of water (\~25-50 μl) at the opening of vaginal canal. The liquid will spontaneously aspirate into the canal without tip insertion. Slowly release the pressure exerted on the bulb. The fluid will withdraw back into the tip. Avoid releasing pressure too quickly to prevent aspiration of fluid into the bulb. A filtered tip may be useful for this purpose.

6.  Repeat the previous step 4-5 times using the same tip, bulb, and fluid to obtain a sufficient number of cells in a single sample.

7.  Place the fluid on glass slide, and allow the smear to completely dry at room temperature. Once dry, these estrous smears can be stained immediately or stored and stained at a later date.

3. Cytological Staining using Crystal Violet\*^4^
-------------------------------------------------

1.  Place the dry slide in a coplin jar (or other comparable staining vessel) containing the crystal violet stain for 1 min.

2.  Remove to a second coplin jar containing ddH~2~O. Wash the slide with ddH~2~O for 1 min. Repeat.

3.  Remove the excess ddH~2~O from the edges of the slide with a light-duty tissue wiper, avoiding contact with the stained smear.

4.  Pipette approximately 15 μl of glycerol on top of the smear and coverslip. Alternatively, other histological mounting reagents can be utilized to obtain a more permanent, non-diffusing stain.

\* The staining method described here is the simplest procedure that can be performed in any laboratory. Other methods can provide additional details. For example, using Papanicolaou staining, the maturity of nucleated epithelial cells can be distinguished with less mature cells stained turquoise and more mature cells pink- or orange-stained. These differences can be used to stage early or late proestrus.^4^

4. Vaginal Cytology
-------------------

1.  Examine the smear under light microscopy to determine cell types present. Microscopic examination should be done immediately after staining as the crystal violet will diffuse from the cells over time when using glycerol for coverslipping. Photomicrographs should be taken at time of analysis to document cytology.

2.  Start by examining the entire smear at a lower magnification. Select a representative area and move to a higher magnification. You will see cornified squamous epithelial cells, leukocytes, and/or nucleated epithelial cells (*representative results*, **Figure 1A-C**). The ratio of cells present will allow you to determine the estrous stage of your mouse at time of sample collection (*representative results*, **Figure 1D-G**) and her immediate hormonal status (*discussion*, **Figure 2**).

5. Representative Results
-------------------------

*Cytology:* Three primary cell types can be detected in vaginal smear samples: (1) nucleated epithelial cells (**Figure 1A**), (2) cornified squamous epithelial cells (**Figure 1B**), and (3) leukocytes (**Figure 1C**). Nucleated epithelial cells have a lightly stained cytoplasm, darker stained plasma membrane, and an oval nucleus (**Figure 1A**). Cornified squamous epithelial cells are uniformly stained, more polygonal in shape than their nucleated epithelial predecessors, and lack a nucleus (**Figure 1B**). Polymorphonuclear leukocytes can be distinguished from epithelial cells by their irregular shape, darkly stained polymorphic nuclei, and small size (**Figure 1C**, black arrows). Should urine contamination be present in the smear, uric acid crystals are readily detected by their crystalline structures dissimilar to any expected cell types (**Figure 3**). Should this occur, and obscure detection of predominant cell type, the smear should be discarded and not used for staging purposes.

*Staging:* The relative ratio of cell types observed in smears can be used to identify the stage of the estrous cycle of your mouse on the day of sample collection (**Figure 1D-G**). During proestrus, cells are almost exclusively clusters of round, well-formed nucleated epithelial cells (**Figure 1D**, representative cell indicated by white arrow). During estrus, cells are predominantly cornified squamous epithelial cells, present in densely packed clusters (**Figure 1E**, representative cell indicated by arrowhead). During metestrus, small darkly stained leukocytes predominate (**Figure 1F**, representative cell indicated by black arrow). Cornified squamous epithelial cells may be observed, often in fragments, (**Figure 1F**, representative cell indicated by black arrowhead). During diestrus, rare cornified squamous epithelial cells may still be present (**Figure 1G**, representative cell indicated by black arrowhead), however leukocytes still predominate (**Figure 1G**, representative cell indicated by black arrow). Metestrus can be distinguished from diestrus by the appearance of nucleated epithelial cells in diestrus (**Figure 1G**, representative cell indicated by white arrow).

**Figure 1. Cytological assessment of vaginal smears can be used to identify estrous stage.** Three main cell types are detected in vaginal smear samples: (A) nucleated epithelial cells, (B) cornified squamous epithelial cells, and (C) leukocytes. The ratio of these cell types present in the smear can be used to identify mice in (D) proestrus, (E) estrus, (F) metestrus, or (G) diestrus as described in *representative results*. Black arrowheads in E, F and G point to representative cornified squamous epithelial cells. Black arrows in C, F and G point to representative leykocytes. White arrows in D and G highlight representative nucleated epithelial cells.

**Figure 2. Vaginal smear cytology reflects underlying endocrine events.** Details are also provided in Discussion. [Click here to view larger figure](http://www.jove.com/files/ftp_upload/4389/4389fig2large.jpg).

**Figure 3. Uric acid crystals may be present following crystal violet staining of urine-contaminated samples.** (A) Crystals are transparent and can be of various sizes (arrows and boxed region magnified in (B)). No cells are present in this field. Should uric acid crystal contamination within fields used for cytological staining be present, it may be difficult to accurately identify cell types present and the smear should be discarded. Scale bars = 50 μm.

Discussion
==========

These changes in cell typology are indicative of underlying endocrine events. The proestrus phase of the estrous cycle corresponds to the human follicular phase of the menstrual cycle^5^ and is defined by a pre-ovulatory increase in circulating 17-β-estradiol levels^6^, as well as a small surge in prolactin^7^ (**Figure 2**, Proestrus, left panel). The increase in 17-β-estradiol indirectly stimulates gonadotropin-releasing hormone neurons in the hypothalamus and septum that, in turn, activate responsive cells in the anterior pituitary to release luteinizing hormone and follicle-stimulating hormone into the circulation^8,9^ (**Figure 2**, Proestrus, left panel). In vaginal smears taken from animals in proestrus, cells are almost exclusively oval nucleated epithelial cells (**Figure 1D**, **Figure 2**, Proestrus, right panel). The peak in follicle-stimulating hormone levels signals ovulation and entry into estrus^10,11^. During estrus, 17-β-estradiol levels decline and prolactin levels peak^6,7^ (**Figure 2**, Estrus, left panel). Vaginal smears are characterized by almost exclusive detection of irregular-shaped cornified squamous epithelial cells often in clumps (**Figure 1E**, **Figure 2**, Estrus, right panel). Entry into metestrus coincides with a continuous rise in progesterone hormone levels^6^ and corresponds to the beginning of human luteal phase^12^ (**Figure 2**, Metestrus, left panel). As progesterone levels start to rise and there is a small surge in 17-β-estradiol levels in response to corpus luteum activation^6,13,14^ (**Figure 2**, Metestrus, left panel). The cell types present in vaginal smears during this stage are fragmented, cornified epithelial cells and smaller darker stained leukocytes (**Figure 1F**, **Figure 2**, Metestrus, right panel). Finally, entry into diestrus in mice occurs and circulating progesterone levels peak^6^, corresponding to the human late luteal phase^12^. Regression of the corpus luteum leads to a subsequent sharp decline in progesterone levels^15,16^ (**Figure 2**, Diestrus, left panel). Leukocytes predominate in smears during diestrus. The frequency of cornified epithelial cells is reduced and nucleated epithelial cells begin to be detected just prior to transition to proestrus (**Figure 1G**, **Figure 2**, Diestrus, right panel).

In summary, this simple, routine protocol can be used to estimate daily hormonal fluctuations and establish estrous stage in experimental mice without altering reproductive status if the following precautions are taken. Sampling should be performed no more than once daily using the non-invasive protocol described here as compared to repeated penetration of the vaginal canal, aspiration, and agitation. This can cause vaginal irritation resulting in an inflammatory response^17^ resulting in leukocytes and other cell types to be present in smears that may confound cytological assessment. Moreover, even in colony-housed females, it is normal to see extended diestrus and estrus stages in different mice as well induction of anestrous^18^ and this identification is useful in the interpretation of hormonal impact in reproductive, gender, and disease studies. Variability in cycle length is also introduced with age and by housing differences within colonies (individual or group-housing) of females^7,19-21^. Females housed in female-only colonies can cease cycling and enter a state of prolonged diestrus^18,22,23^ although cycling can be re-instated by exposure to cages pretreated with male urine to elicit cycling^24,25^. Thus, to establish individual cycle lengths for a given mouse, it is recommended that the non-invasive assessments described here be performed daily, with care, until two complete cycles are observed.
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